Publications
Fragment-Based Design of Mycobacterium Tuberculosis InhA Inhibitors
(2020)
(doi: 10.26434/chemrxiv.10280849)
Fragment-Based Design of Mycobacterium Tuberculosis InhA Inhibitors
(2020)
InhibitingMycobacterium tuberculosisCoaBC by targeting a new allosteric site
(2019)
(doi: 10.1101/870154)
Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors.
Advances in Experimental Medicine and Biology
(2019)
1163
253
(doi: 10.1007/978-981-13-8719-7_11)
Fragment-Based Design of Mycobacterium Tuberculosis InhA Inhibitors
(2019)
Covalent inactivation of Mycobacterium thermoresistibile inosine-5'-monophosphate dehydrogenase (IMPDH).
Bioorganic & Medicinal Chemistry Letters
(2019)
30
126792
(doi: 10.1016/j.bmcl.2019.126792)
Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding Mode.
J Med Chem
(2019)
62
10586
(doi: 10.1021/acs.jmedchem.9b01203)
Structural insights into Escherichia coli phosphopantothenoylcysteine synthetase by native ion mobility-mass spectrometry.
Biochemical Journal
(2019)
476
3125
(doi: 10.1042/BCJ20190318)
The Application of Fragment-based Approaches to the Discovery of Drugs for Neglected Tropical Diseases
(2019)
18
(doi: 10.1201/9781351011655-2)
Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
Current medicinal chemistry
(2019)
26
2234
- ‹ previous
- Page 4